Vera Rebmann

8PUBLICATIONS
14CO-AUTHORS
Innate immunityPredictive and prognostic markersInfectious diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 23, 2022
Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells.

Hana Rohn, Cordula Lang, Sabine Schramm

|Apr 02, 2022
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse.

Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner

|Oct 13, 2021
Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age.

Margarethe Konik, Monika Lindemann, Markus Zettler

|Nov 21, 2020
Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma.

Bettina Wagner, Ulrich Dührsen, Andreas Hüttmann

|Aug 10, 2019
HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.

Hana Rohn, Rafael Tomoya Michita, Sabine Schramm

|Apr 17, 2019
Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness.

Lambros Kordelas, Esther Schwich, Robin Dittrich

Pageof 2

Frequent Collaborators

3 joint publications

Mirko Trilling

2 joint publications

Rafael Tomoya Michita

1 joint publications

Peter Schenker

1 joint publications

Lambros Kordelas